0%
0%
0%
0%
0%
About Adial Pharmaceuticals, Inc
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Cary J. Claiborne
Website
adialpharma.com
Headquarters
Charlottesville
Employees
20
Founded
2010
ISIN
US00688A1144
Adial Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the treatment of alcohol use disorder. Its lead product is AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson & William B. Stilley in November 2010 and is headquartered in Charlottesville, VA.
